Rish K Pai1, John Hart, Amy E Noffsinger. 1. Department of Pathology, The University of Chicago Medical Center, Chicago, IL, USA. rpai@path.wustl.edu
Abstract
AIMS: To determine the prevalence of various colonic polyps removed during a recent 8-month period; to determine the interobserver agreement in the diagnosis of serrated polyps; and to determine if harbouring a sessile serrated adenoma (SSA) predisposes to the presence of synchronous polyps with similar histology. METHODS AND RESULTS: All polyps resected during an 8-month period at a single tertiary medical centre were analysed. We also analysed all polyps in patients with an SSA or SSA with dysplasia since 2003. SSAs accounted for 4.3% of colonic polyps removed during an 8-month period. A review of 276 serrated polyps by two pathologists revealed good interobserver agreement (kappa = 0.66). Patients with one SSA were more likely to harbour additional serrated polyps. After removal of the index SSA, 18% of their remaining polyps were SSAs, SSAs with dysplasia, and traditional serrated adenomas, contrasting with the approximately 5% prevalence of these polyps in the control population. The hyperplastic polyps in the study population were also twice as likely to occur proximal to the splenic flexure. CONCLUSIONS: These data indicate that there is a strong colonic mucosal field defect in patients with sporadic SSAs that predispose them to develop additional serrated polyps.
AIMS: To determine the prevalence of various colonic polyps removed during a recent 8-month period; to determine the interobserver agreement in the diagnosis of serrated polyps; and to determine if harbouring a sessile serrated adenoma (SSA) predisposes to the presence of synchronous polyps with similar histology. METHODS AND RESULTS: All polyps resected during an 8-month period at a single tertiary medical centre were analysed. We also analysed all polyps in patients with an SSA or SSA with dysplasia since 2003. SSAs accounted for 4.3% of colonic polyps removed during an 8-month period. A review of 276 serrated polyps by two pathologists revealed good interobserver agreement (kappa = 0.66). Patients with one SSA were more likely to harbour additional serrated polyps. After removal of the index SSA, 18% of their remaining polyps were SSAs, SSAs with dysplasia, and traditional serrated adenomas, contrasting with the approximately 5% prevalence of these polyps in the control population. The hyperplastic polyps in the study population were also twice as likely to occur proximal to the splenic flexure. CONCLUSIONS: These data indicate that there is a strong colonic mucosal field defect in patients with sporadic SSAs that predispose them to develop additional serrated polyps.
Authors: Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Manish Singla; Jean D Kemp; Michael E Goldberg; Vito V Cirigliano; Gilda M Bobele; Ganesh R Veerappan; Patrick E Young Journal: Turk J Gastroenterol Date: 2021-10 Impact factor: 1.852
Authors: Christoph Schramm; Moritz Kaiser; Uta Drebber; Inga Gruenewald; Jeremy Franklin; Fabian Kuetting; Andrea Bowe; Vera Hoffmann; Sebastian Gatzke; Ulrich Toex; Hans-Michael Steffen Journal: Int J Colorectal Dis Date: 2015-09-29 Impact factor: 2.571
Authors: Aedan Roberts; Derek Nancarrow; Mark Clendenning; Daniel D Buchanan; Mark A Jenkins; David Duggan; Darin Taverna; Diane McKeone; Rhiannon Walters; Michael D Walsh; Bruce W Young; Jeremy R Jass; Christophe Rosty; Michael Gattas; Elise Pelzer; John L Hopper; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry Phillips; Susan Parry; Sonja Woodall; Julie Arnold; Kathy Tucker; Amanda Muir; Musa Drini; Finlay Macrae; Polly Newcomb; John D Potter; Erika Pavluk; Annika Lindblom; Joanne P Young Journal: Fam Cancer Date: 2011-06 Impact factor: 2.375
Authors: Christophe Rosty; David G Hewett; Ian S Brown; Barbara A Leggett; Vicki L J Whitehall Journal: J Gastroenterol Date: 2012-12-04 Impact factor: 7.527